home / press / releases

Menu
  • Search all tables

releases: https://www.wicker.senate.gov/2026/11/16/wicker-colleagues-introduce-legislation-to-support-families-facing-rare-childhood-diseases/

One row per release. Full-text search runs over title + body text.

Data license: MIT · Data source: dwillis/congress-press

This data as json

url title date year month party chamber state member_name bioguide_id domain scraper source date_source text has_text collected_at updated_at
https://www.wicker.senate.gov/2026/11/16/wicker-colleagues-introduce-legislation-to-support-families-facing-rare-childhood-diseases/ Wicker, Colleagues Introduce Legislation to Support Families Facing Rare Childhood Diseases 2026-11-16 2026 2026-11 Republican Senate MS Roger F. Wicker W000437 www.wicker.senate.gov wicker https://www.wicker.senate.gov/category/press-releases/ scraper WASHINGTON – U.S. Senators Roger Wicker, R-Miss., Amy Klobuchar, D-Minn., Eric Schmitt, R-Mo., and Chris Coons, D-Del., today introduced the Genomic Answers for Children’s Health Act of 2026. This legislation would clarify that Medicaid must cover genomic sequencing for children with suspected rare diseases or genetic disorders who are enrolled in the program. “Parents of children with rare diseases often spend years waiting for a diagnosis. Even when test results arrive, the answers can be frustratingly inconclusive,” said Senator Wicker. “Genomic sequencing offers families faster and more reliable results. Through early detection, more patients will be able to get the care they need without endless delays and extensive testing, saving families and providers money in the long run.” “For parents, few things are harder than knowing your child needs help and not having answers or knowing what options are available to help them. By expanding access to genomic sequencing for children with suspected rare diseases and genetic disorders, we can help parents get answers faster, doctors make more accurate diagnoses, and ensure families can get the care their children need,” said Klobuchar. “This bipartisan bill is an important step toward improving health outcomes and saving children’s lives.” “As the father of a child with a rare medical condition, I understand firsthand the challenges Missouri families like mine face. Worrying about the cost of care should be the last thing on a parent’s mind. By ensuring Medicaid covers genomic sequencing for children with rare diseases, Missouri families will be able to better access the answers and care their children need,” said Senator Schmitt. “When your child is sick, there’s nothing you wouldn’t give to make them better,” said Senator Coons. “For millions of families across the nation whose children have a rare disease, they are left waiting and waiting for the answers and treatments they need. This bill brings an end to the waiting, giving families access to the keys that could unlock their children’s futures.” Background on the Genomic Answers for Children’s Health Act of 2026: Approximately 30 million Americans suffer from rare diseases, and half of these patients are children. For many, the diagnosing process can take between four to eight years, and it can still yield inaccurate results and amount to thousands of dollars in medical costs. Genomic sequencing—a type of testing that examines an individual’s entire DNA sequence—is a more efficient and accurate alternative. If signed into law, Senator Wicker’s bill would: Require Medicaid to cover whole genome sequencing and whole exome sequencing as mandatory benefits for enrollees under the age of 21 Direct states to expand access to genomic testing in hospital settings Instruct the Secretary of Health and Human Services to raise awareness about genomic sequencing As Chairman of the Senate’s Rare Disease Caucus, Senator Wicker has been a leader in strengthening medical research and expanding access to care for individuals suffering from extraordinary health conditions. When he served as a member of the House of Representatives, Wicker authored the MD CARE Act, which allocated extensive funding for research dedicated to Duchenne Muscular Dystrophy (DMD). Last year, Senator Wicker introduced the Scientific EXPERT Act, which would allow the Food and Drug Administration (FDA) to use findings and insights from medical experts in its work to improve outcomes for patients battling rare diseases. The full text of the bill is available here. ### 1 2026-11-17T14:08:02Z 2026-11-17T14:09:02Z
Powered by Datasette · Queries took 0.958ms · Data license: MIT · Data source: dwillis/congress-press